2007
DOI: 10.1093/jac/dkm497
|View full text |Cite
|
Sign up to set email alerts
|

Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use

Abstract: While rapid bacterial identification and susceptibility testing led to earlier changes and a significant reduction in antibiotic use, they did not reduce mortality.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
180
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 205 publications
(184 citation statements)
references
References 17 publications
3
180
0
1
Order By: Relevance
“…The benefits of timely microbiological testing of blood cultures for patient management are under active investigation and may arise primarily from optimized and pathogen-directed antibiotic use (16,20,21 ), resulting in decreases in side effects, antibiotic resistance (22,23 ), and therapy costs (16,17 ). The first published evidence suggests that faster bacterial identification by MALDI-TOF MS or PCR does indeed increase the appropriateness of knowledge-based antibiotic treatment of bacteremia (24,25 ), properly reducing therapy and hospitalization costs (17 ).…”
Section: Discussionmentioning
confidence: 99%
“…The benefits of timely microbiological testing of blood cultures for patient management are under active investigation and may arise primarily from optimized and pathogen-directed antibiotic use (16,20,21 ), resulting in decreases in side effects, antibiotic resistance (22,23 ), and therapy costs (16,17 ). The first published evidence suggests that faster bacterial identification by MALDI-TOF MS or PCR does indeed increase the appropriateness of knowledge-based antibiotic treatment of bacteremia (24,25 ), properly reducing therapy and hospitalization costs (17 ).…”
Section: Discussionmentioning
confidence: 99%
“…16 Re-assessment of empirical antimicrobial therapy with the help of the microbiological results after 2-3 days allows for de-escalation to targeted, narrower-spectrum antibiotics appropriate to the susceptibilities of the pathogens isolated. A clinical example of de-escalation strategy is shown in the Appendix and illustrates how de-escalation works in an individual patient.…”
Section: Swift Reporting Of Positive Clinical Cultures and Implementamentioning
confidence: 99%
“…point of care | UTI | AST | antibiotic | resistance | microfluidic W ith the ever-increasing emergence and spread of antibioticresistant bacteria, a key factor in correct treatment of infections is the ability to rapidly identify the antibiotic susceptibility profile of the infecting species to assure the use of an efficacious antibiotic and reduce the need for broad spectrum drugs (1)(2)(3). Phenotypic antibiotic susceptibility tests (ASTs) are typically based on the detection of differential bacterial growth with and without antibiotics in liquid cultures or on solid agar plates (4).…”
mentioning
confidence: 99%